All news (page 147)

21 October 2025

MOL Danube Refinery Fire Incident

A fire at the Danube Refinery's AV3 plant was contained. No injuries reported. Authorities monitor air quality. Hungarian fuel supply remains secure. Investigation and damage assessment ongoing.
21 October 2025

Port of Antwerp-Bruges: Mixed Results Amid Volatile Market

Container traffic stabilizes, bulk declines due to global uncertainty. US tariffs impact exports. European chemical sector faces challenges. RoRo and US trade show growth.
20 October 2025

Perpetual Next Appoints Gervais Green to Supervisory Board, Continues Partnership with ING Corporate Finance

Gervais Green joins to enhance governance and international growth. Collaboration with Fluor and ING supports biomethanol expansion and strategic partner admission.
20 October 2025

Repsol and NCLH Sign 8-Year Renewable Fuel Deal in Barcelona

Starting 2026, renewable marine fuels, including biofuels and methanol, will be supplied at the Port of Barcelona, supporting decarbonization and circular economy goals.
20 October 2025

NEXTCHEM to Conduct Feasibility Study for Waste-to-Methanol Project in Norway

The project explores converting waste to low-carbon methanol at Mongstad, aiding compliance with EU regulations for marine and aviation fuels.
20 October 2025

Lummus Technology Secures Consecutive Technology Licensor of the Year Award

Lummus also won Best Refining Technology for CDDMESM. They were finalists in four other categories, highlighting their innovation and leadership in the energy sector.
20 October 2025

TotalEnergies Sells GreenFlex to Oteis for Sustainable Consultancy Expansion

Oteis acquires GreenFlex to enhance its sustainable consultancy services, while TotalEnergies focuses on energy production. GreenFlex gains market expansion opportunities.
20 October 2025

Merck Begins $3B Pharmaceutical Facility Construction in Virginia

Merck invests $70B in U.S. manufacturing and R&D, creating 500+ full-time and 8,000 construction jobs in Virginia, enhancing biopharmaceutical innovation and domestic production.
20 October 2025

Johnson & Johnson's INLEXZO™ and Cetrelimab Show Promising Pre-Surgical Results in Bladder Cancer

Phase 2b study shows INLEXZO™ plus cetrelimab achieves significant pathologic response rates in muscle invasive bladder cancer patients ineligible for platinum-based chemotherapy.
20 October 2025

Novo Nordisk to Present Oral Semaglutide and Obesity Data at ObesityWeek 2025

New data on oral semaglutide and CagriSema will be presented, focusing on weight loss efficacy, cardiometabolic health, and women's health in obesity management.
20 October 2025

Elkem Reduces Ferrosilicon Output in Norway and Iceland

Production cut due to weak European market and EU import investigation. Temporary layoffs possible. Aims to lower inventory and stabilize market.
20 October 2025

ORLEN Enhances Hydrogen Capabilities in Pomerania with Expert Support

Amber Hydrogen Valley receives expert advisory to optimize costs and guide it to final investment decision, aiming to build a full hydrogen value chain in Pomerania.
20 October 2025

Croda Reveals New Data on KeraBio K31 Hair Repair Innovation

KeraBio K31 offers potent hair repair at low concentrations, enhancing sustainability. It's 99% natural, vegan, and shortlisted for a Product Innovation Award.
20 October 2025

LYB Invests in R&D to Improve Mechanical Recycling Quality

LYB enhances recycling with advanced sorting, decontamination, and analytics for safer, high-quality recyclates, focusing on different technologies for various plastic waste types.
20 October 2025

WuXi Biologics Receives 2025 Global Customer Value Leadership Award from Frost & Sullivan

Recognized for innovation and operational excellence, the company supports 864 projects, achieving a 98% success rate in manufacturing and passing 44 global regulatory inspections.
20 October 2025

bp Announces Discovery in Namibia's Orange Basin

Volans-1X well in Orange Basin finds 26m of gas condensate reservoirs with high CGR. Third major 2025 discovery for Azule Energy partners. Further evaluation ongoing.
20 October 2025

Elkem Backs Local Silicone Supply Chain in Saudi Arabia

A joint venture aims to localize silicone production in Saudi Arabia, enhancing supply chain sustainability and supporting industrial growth in line with Vision 2030.
20 October 2025

Roche's Tecentriq Enhances Survival in Bladder Cancer with ctDNA-Guided Treatment

Tecentriq reduces death risk by 41% and recurrence by 36% in bladder cancer using ctDNA guidance, sparing low-risk patients from unnecessary treatment.
20 October 2025

Roche's Gazyva Approved by FDA for Lupus Nephritis Treatment

FDA approves Gazyva for lupus nephritis, showing superior results in trials, offering a new treatment option to prevent kidney disease progression.
20 October 2025

Holcim Acquires Xella

Holcim to acquire Xella, enhancing sustainable walling solutions. Deal valued at EUR 1.85B, EPS and cash flow accretive in year one, closing expected H2 2026.
19 October 2025

NEXTCHEM Conducts Feasibility Study for Waste-to-Methanol Project in Norway

The project explores converting waste to low-carbon methanol at Mongstad, aiming to replace marine fuel and produce Sustainable Aviation Fuel.
19 October 2025

Johnson & Johnson's Subcutaneous Amivantamab Shows 45% Response Rate in Head and Neck Cancer

Subcutaneous amivantamab offers rapid, durable responses in head and neck cancer, with 82% tumor shrinkage and a median response duration of 7.2 months.
19 October 2025

Raludotatug Deruxtecan Shows 50.5% Response in Platinum-Resistant Ovarian Cancer, Reports Daiichi Sankyo and Merck

Raludotatug deruxtecan achieved a 50.5% response rate in phase 2 for platinum-resistant ovarian cancer, with a 5.6 mg/kg dose selected for phase 3.
18 October 2025

Genmab Reports Positive Phase 1/2 Trial Results for Rina-S in Advanced Endometrial Cancer

Rina-S shows 50% response rate in advanced endometrial cancer trial; FDA grants Breakthrough Therapy Designation.
18 October 2025

Merck and Eisai: KEYTRUDA and LENVIMA Show 5-Year Survival Benefit in Advanced Endometrial Carcinoma

KEYTRUDA and LENVIMA improve 5-year survival rates in advanced endometrial carcinoma compared to chemotherapy, with consistent results across patient subgroups.
18 October 2025

Merck's KEYTRUDA Plus Chemotherapy Reduces Disease Progression Risk in Platinum-Resistant Ovarian Cancer

KEYTRUDA with chemotherapy shows significant survival benefits in platinum-resistant ovarian cancer, leading to FDA priority review for expanded use.
18 October 2025

Merck: KEYTRUDA and Padcev Cut Bladder Cancer Risks Pre- and Post-Surgery

KEYTRUDA and Padcev improve survival rates in muscle-invasive bladder cancer patients ineligible for cisplatin, showing significant event-free and overall survival benefits.
17 October 2025

Roche Unveils Phase III Data for Vamikibart in Uveitic Macular Edema

Vamikibart shows promise in treating UME, with significant vision improvements in trials, offering a non-steroid alternative with fewer side effects.
17 October 2025

FDA Approves Novo Nordisk's Oral Semaglutide for CV Risk Reduction in High-Risk Type 2 Diabetes Adults

Oral semaglutide reduces major cardiovascular events in high-risk type 2 diabetes patients, showing a 14% risk reduction over 4 years, with consistent safety profile.
17 October 2025

Brenntag Opens Food & Nutrition Innovation Center in Leeds

The Leeds center focuses on R&D for food applications, offering ingredient selection, formulation support, and technical solutions for UK and Ireland food manufacturers.

← Previous Next →